1. Naturally occurring affectors of initial step of protein biosynthesis 2. Physicochemical, biochemical and cell biology properties and byproducts of tryptamine and other "trace" amines 3. Tryptophan metabolites and biogenic amines in physical exercises 4. Tryptamine in inflammation and regulation of gene transcription 5. Genes encoding mammalian, plant and microbial aromatic amino acid decarboxylase 6. Decarboxylases producing tryptamine and other biogenic amines in human microbiome 7. Microbial shikimate pathway in diseases 8.

Biogenic amines in fasting, feeding and stress conditions 9. Metabolites of shikimate and tryptophan pathways in Corona virus disease (COVID-19) 10. Virulence factors 11. Relation of human gut Alzheimer's disease associated sequence (ADAS) with shikimate pathway metabolites 12. Benefits of using fecal microbiota transplantation as treatment have been controversial 13. Shikimate pathway enzymes in human microbiome 14. Tryptophan operon in human microbiome and inhibitors of tryptophan operon enzymes 15. Antibodies to tryptamines 16.

Cell death in Alzheimer's disease brain and tryptamine-treated cells.